Gene expression profiling in the discovery, optimization and development of novel drugs: one universal screening platform (Q36412671)

14 August 2017

1 reference

title

Gene expression profiling in the discovery, optimization and development of novel drugs: one universal screening platform (English)

1 reference

14 August 2017

0 references

David Bol

1 reference

14 August 2017

Reinhard Ebner

series ordinal

1 reference

14 August 2017

publication date

1 March 2006

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

14 August 2017

page(s)

227-235

1 reference

Biomarkers in cancer staging, prognosis and treatment selection

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Receptor-targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Clinical Experience with Trastuzumab (Herceptin)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Pharmacogenomics and the drug discovery pipeline: when should it be implemented?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

How molecular profiling could revolutionize drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

A quantitative genomic expression analysis platform for multiplexed in vitro prediction of drug action.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Interplay of transcriptomics and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Proteomic profiling of cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Prediction of drug sensitivity and drug resistance in cancer by transcriptional and proteomic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Biological Mechanism Profiling Using an Annotated Compound Library

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Exploring biology with small organic molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Chemical genetics: ligand-based discovery of gene function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Using genome-wide transcriptional profiling to elucidate small-molecule mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

A gene expression database for the molecular pharmacology of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Chemosensitivity prediction by transcriptional profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Transcriptomic analysis of the NCI-60 cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Advances in chemical genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

An expression screen reveals modulators of class II histone deacetylase phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Transcriptional-based screens for pathway-specific, high-throughput target discovery in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Multicomponent therapeutics for networked systems

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Adenomatous polyposis coli/beta-catenin interaction and downstream targets: altered gene expression in gastrointestinal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Wnt breakers in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

beta-catenin: molecular plasticity and drug design.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Wnt/beta-catenin signaling pathway as a novel cancer drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Protein-protein interactions and cancer: small molecules going in for the kill

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Dissecting Wnt/beta-catenin signaling during gastrulation using RNA interference in mouse embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Investigating Wnt signaling: a chemogenomic safari

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

beta-catenin-mediated signaling: a molecular target for early chemopreventive intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Effect of indomethacin on E-cadherin and beta-catenin expression in HT-29 colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.227

21 January 2018

Identifiers

DOI

10.2217/14622416.7.2.227

1 reference

14 August 2017

1 reference